NASDAQ:ASBP | Free Cash Flow | Aspire Biopharma Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.04M
2025-12-31-$927,841.00
2025-03-31-$1.75M
2024-12-31$479,569.00
2024-03-31-$192,971.00
2023-12-31-$156,128.00
2023-03-31-$182,107.00
2022-12-31-$35,870.00
2022-03-31-$1.29M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$4.92M
2024-12-31-$265,186.00
2023-12-31-$653,107.00
2022-12-31-$1.41M